Add Note Why Create Notes?

Capture your thoughts

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Walt Disney Co NYSE:DIS	Media

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

This note will be permanently deleted.

Delete

Cancel

Have any thoughts about
GeneDx Holdings Corp?

Write Note

Write Note Ask AI

Ask me anything about

GeneDx Holdings Corp

What unique competitive advantages
does GeneDx Holdings Corp hold over its rivals?

What risks and challenges
does GeneDx Holdings Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of GeneDx Holdings Corp.

What unique competitive advantages
does GeneDx Holdings Corp hold over its rivals?

What risks and challenges
does GeneDx Holdings Corp face in the near future?

Has there been any significant insider trading activity
in GeneDx Holdings Corp recently?

Summarize the latest earnings call
of GeneDx Holdings Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for GeneDx Holdings Corp.

Provide P/S
for GeneDx Holdings Corp.

Provide P/E
for GeneDx Holdings Corp.

Provide P/OCF
for GeneDx Holdings Corp.

Provide P/FCFE
for GeneDx Holdings Corp.

Provide P/B
for GeneDx Holdings Corp.

Provide EV/S
for GeneDx Holdings Corp.

Provide EV/GP
for GeneDx Holdings Corp.

Provide EV/EBITDA
for GeneDx Holdings Corp.

Provide EV/EBIT
for GeneDx Holdings Corp.

Provide EV/OCF
for GeneDx Holdings Corp.

Provide EV/FCFF
for GeneDx Holdings Corp.

Provide EV/IC
for GeneDx Holdings Corp.

Show me price targets
for GeneDx Holdings Corp made by professional analysts.

What are the Revenue projections
for GeneDx Holdings Corp?

How accurate were the past Revenue estimates
for GeneDx Holdings Corp?

What are the Net Income projections
for GeneDx Holdings Corp?

How accurate were the past Net Income estimates
for GeneDx Holdings Corp?

What are the EPS projections
for GeneDx Holdings Corp?

How accurate were the past EPS estimates
for GeneDx Holdings Corp?

What are the EBIT projections
for GeneDx Holdings Corp?

How accurate were the past EBIT estimates
for GeneDx Holdings Corp?

Compare the revenue forecasts
for GeneDx Holdings Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of GeneDx Holdings Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of GeneDx Holdings Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of GeneDx Holdings Corp compared to its peers.

Compare the P/E ratios
of GeneDx Holdings Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing GeneDx Holdings Corp with its peers.

Analyze the financial leverage
of GeneDx Holdings Corp compared to its main competitors.

Show all profitability ratios
for GeneDx Holdings Corp.

Provide ROE
for GeneDx Holdings Corp.

Provide ROA
for GeneDx Holdings Corp.

Provide ROIC
for GeneDx Holdings Corp.

Provide ROCE
for GeneDx Holdings Corp.

Provide Gross Margin
for GeneDx Holdings Corp.

Provide Operating Margin
for GeneDx Holdings Corp.

Provide Net Margin
for GeneDx Holdings Corp.

Provide FCF Margin
for GeneDx Holdings Corp.

Show all solvency ratios
for GeneDx Holdings Corp.

Provide D/E Ratio
for GeneDx Holdings Corp.

Provide D/A Ratio
for GeneDx Holdings Corp.

Provide Interest Coverage Ratio
for GeneDx Holdings Corp.

Provide Altman Z-Score Ratio
for GeneDx Holdings Corp.

Provide Quick Ratio
for GeneDx Holdings Corp.

Provide Current Ratio
for GeneDx Holdings Corp.

Provide Cash Ratio
for GeneDx Holdings Corp.

What is the historical Revenue growth
over the last 5 years for GeneDx Holdings Corp?

What is the historical Net Income growth
over the last 5 years for GeneDx Holdings Corp?

What is the current Free Cash Flow
of GeneDx Holdings Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for GeneDx Holdings Corp.

GeneDx Holdings Corp
NASDAQ:WGS

Watchlist Manager

GeneDx Holdings Corp

NASDAQ:WGS

Watchlist

Earnings Calls

Price: 27.04 USD 5.3% Market Closed

Updated: Jun 12, 2024

P/S
Price to Sales

3.2

Current

Median

2.3

Industry

Higher than median

Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S

3.2

Market Cap

706.3m

Revenue

221.9m

All Countries

Forward Multiples

			Market Cap	P/S
US		GeneDx Holdings Corp NASDAQ:WGS	706.3m USD	3.2
US		Cigna Corp NYSE:CI	96B USD	0.5
US	C	Cigna Group XMUN:CGN	88.9B EUR	0.5
US		CVS Health Corp NYSE:CVS	75.1B USD	0.2
DE		Fresenius SE & Co KGaA XETRA:FRE	16.6B EUR	0.6
US		Laboratory Corporation of America Holdings NYSE:LH	16.6B USD	1.4
US		Quest Diagnostics Inc NYSE:DGX	15.6B USD	1.7
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.5B EUR	0.6
DE		Fresenius Medical Care AG XMUN:FME	11.5B EUR	0.6
US		DaVita Inc NYSE:DVA	12.3B USD	1
US		Oak Street Health Inc NYSE:OSH	9.5B USD	4.4

				Revenue Growth
US		GeneDx Holdings Corp NASDAQ:WGS	Average P/S: 1.3 3.2	63%
US		Cigna Corp NYSE:CI	0.5	43%
US	C	Cigna Group XMUN:CGN	0.5	43%
US		CVS Health Corp NYSE:CVS	0.2	16%
DE		Fresenius SE & Co KGaA XETRA:FRE	0.6	25%
US		Laboratory Corporation of America Holdings NYSE:LH	1.4	21%
US		Quest Diagnostics Inc NYSE:DGX	1.7	10%
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.6	10%
DE		Fresenius Medical Care AG XMUN:FME	0.6	10%
US		DaVita Inc NYSE:DVA	1	13%
US		Oak Street Health Inc NYSE:OSH	4.4	156%

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/S

2.9

2-Years Forward

P/S

2.5

3-Years Forward

P/S

2.1

GeneDx Holdings Corp
NASDAQ:WGS

P/S
Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

GeneDx Holdings Corp NASDAQ:WGS

P/S Price to Sales

P/S Forward Multiples

See Also

Company

Help

Tools

Stocks

GeneDx Holdings Corp
NASDAQ:WGS

P/S
Price to Sales